Recent extremely meaningful positive changes in investment behavior have benefitted Exact Sciences Corporation (NASDAQ: EXAS): positive upside/downside volume developed, and its longer term price trend turned up.
Recent notable positive changes in fundamentals have benefitted Exact Sciences Corporation (NASDAQ: EXAS): the consensus estimate for December, 2026 increased significantly, and the consensus estimate for December, 2025 increased significantly.
In light of these very positive signals we are reviewing our current Overall Rating of F. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Exact Sciences has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Exact Sciences has a slightly negative Power Rating of 31 and a poor Appreciation Score of 17, producing the Lowest Value Trend Rating.
Recent Price Action
Exact Sciences Corporation (NASDAQ: EXAS) stock rose slightly by 0.2% on 10/7/25. The stock closed at $57.75. However, this advance was accompanied by unusually low trading volume at 61% of normal. The stock has performed in line with the market over the last nine months and has risen 8.2% during the last week.
Be the first to comment